Skip to content

HeartHab, Can a Patient-tailored Application Support Coronary Artery Disease Patients During Rehabilitation?

Pilot Study, How the HeartHab Application Can Support Coronary Artery Disease Patients in Their Rehabilitation Program?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02668757
Acronym
HeartHab
Enrollment
30
Registered
2016-01-29
Start date
2016-03-31
Completion date
2017-12-31
Last updated
2018-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

The HeartHab study is a pilot trial in which coronary artery disease patients (n = 15-30) are given the HeartHab application. The HeartHab application is a smarthphone based mobile application that serves as a secondary prevention tool, to support cardiac patients after their phase II cardiac rehabilitation program. During study period (4-6 weeks), participating patients will be asked to use the application. HeartHab includes a module devoted to therapy compliance, one to exercise training prescription and one to risk factor control. HeartHab aims to motivate the patient to improve his/her self-management skills and hence decrease cardiovascular morbidity (and mortality). Motivational aspects and usability data will be collected during study period by means of app logs and/or questionnaires/interviews.

Interventions

BEHAVIORALHeartHab application intervention

The intervention patients will use the HeartHab application on a smartphone. During the study, the patients will use the HeartHab application for 4-6 weeks.

Sponsors

Hasselt University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients with coronary artery disease for which they received a percutaneous coronary intervention, coronary artery bypass grafting or drugs only. * Patients that have completed the standard cardiac rehabilitation program * Patients who have access to a computer and a WiFi internet connection * Patients that are able to go to the rehabilitation centre ReGo of Jessa Hospital * Patients who signed the informed consent document

Exclusion criteria

* Patients with a history of VF, sustained VT and/or supraventricular tachycardia during the last 6 months before enrollment. * Patients who due to cognitive, neurological and/or musculoskeletal constraints are unable to ride a bicycle. * Patients with a pacemaker or defibrillator. * Non-Dutch speaking patients * Patients who simultaneously participate in another study

Design outcomes

Primary

MeasureTime frameDescription
Impact on motivationweek 6By means of a questionnaire and an interview, questions are asked about participants' motivation for a tour

Secondary

MeasureTime frameDescription
Usability of the HeartHab applicationweek 6By means of a questionnaire and an interview, the participants are asked about the usability of the application. This information will give insights in parts of the application that could be improved considering the usability

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026